FDG-PET-CT scan at the end of treatment for diffuse large B-cell or Burkitt lymphoma

at completion of planned treatment

tests per year, UK, at completion of planned treatment

“Offer FDG‑PET‑CT imaging to assess response at completion of planned treatment for people with: diffuse large B‑cell lymphoma Burkitt lymphoma.”

NICE NG52, Non-Hodgkin's lymphoma: diagnosis and management, recommendation 1.2.4, 2016-07

Kind of source
Clinical guideline
Read on
2026-11-06
Daily check
Quote found at the source on 2026-11-06
What to know
Staging PET-CT is also offered for early-stage disease (recommendation 1.2.1); interim PET-CT during treatment is not routine (1.2.3).

Used in

Kept as evidence; no figure on the platform is computed from it yet.